Results 211 to 220 of about 57,560 (274)

The impact and fate of clarithromycin in anaerobic digestion of waste activated sludge for biogas production

Environmental Research, 2021
Clarithromycin retained in waste activated sludge (WAS) inevitably enters the anaerobic digestion system. So far, the complex impacts and fate of clarithromycin in continuous operated WAS anaerobic digestion system are still unclear.
Guangming Zeng, Jing Sun, Qiuxiang Xu
exaly   +2 more sources

A Novel Stool PCR Test for Helicobacter pylori May Predict Clarithromycin Resistance and Eradication of Infection at a High Rate

Journal of Clinical Microbiology, 2017
Erin Beckman, Ilaria Maria Saracino, Giulia Fiorini   +2 more
exaly   +2 more sources

Polymorphism of clarithromycin

Archives of Pharmacal Research, 2000
It is well recognized that physicochemical properties of drugs are affected by the type of polymorphic crystalline form of drugs. Clarithromycin is known to exist in at least three polymorphic crystalline forms. Since conventional means to obtain the most thermodynamically stable form (Form II) for the antibiotics is known to be associated with a low ...
Y T, Sohn, J K, Rhee, W B, Im
openaire   +2 more sources

Pharmacokinetics and Pharmacodynamics of Tegoprazan Coadministered With Amoxicillin and Clarithromycin in Healthy Subjects

Journal of clinical pharmacology, 2020
This clinical trial was conducted to evaluate the pharmacokinetics and pharmacodynamics of tegoprazan when coadministered with amoxicillin/clarithromycin in healthy subjects.
J. Ghim, M. Chin, J. Jung, Jiwon Lee, Seokuee Kim, Bongtae Kim, G. Song, Young-Kyung Choi, Jae-Gook Shin   +8 more
semanticscholar   +1 more source

Dual Therapy with Vonoprazan and Amoxicillin Is as Effective as Triple Therapy with Vonoprazan, Amoxicillin and Clarithromycin for Eradication of Helicobacter pylori

Digestion, 2019
Backgrounds/Aims: Vonoprazan (VPZ) is the first clinically available potassium competitive acid blocker. This class of agents provides faster and more potent acid inhibition than proton pump inhibitors.
T. Furuta, M. Yamade, Takuma Kagami, T. Uotani, Takahiro Suzuki, Tomohiro Higuchi, Shinya Tani, Yasushi Hamaya, M. Iwaizumi, H. Miyajima, K. Umemura, S. Osawa, K. Sugimoto   +12 more
semanticscholar   +1 more source